News search

    E.g., 25/04/2024
    E.g., 25/04/2024
    María Jesús Andrés, Carla Espinós (detrás), Rosa M Nevado (delante, al lado de MJA), Miguel de la Fuente, Rosa Carmona, Ana Barettino, Vicente Andrés, Pilar Gonzalo e Ignacio Benedicto.
    Research
    19 Apr 2024
    PNAS: CNIC scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

    The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS)
    Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
    Research
    16 Apr 2024
    JACC: CardioOncology: CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

    The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity
    Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
    Research
    1 Feb 2024
    Nature Cardiovascular Research: New approach to the design of therapies that enhance the effect of cholesterol-lowering drugs

    A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs
    David Sancho
    About the CNIC
    31 Oct 2023
    David Sancho wins the 28th Carmen and Severo Ochoa Award for Research in Molecular Biology

    Dr Sancho heads the CNIC Immunobiology Laboratory, whose work focuses on research into the function of dendritic cells and macrophages, as key immune cells that modulate immunity and inflammation, and the use of these cells in immunotherapy in a wide range of diseases
    About the CNIC
    30 Oct 2023
    Dr Valentín Fuster receives the AstraZeneca Foundation Honorific Award for Excellence in Scientific Research

    The Honorific Award for Excellence in Scientific Research is awarded in recognition of the career of scientists who have contributed to the generation of knowledge and advances in their field of specialization
    Generación de células dendríticas post-sinápticas. La imagen muestra los contactos intercelulares entre las células dendríticas y los linfocitos T. Células Dendríticas (verde) y los linfocitos T (azul y rosa)
    Research
    26 Oct 2023
    Nature Communications: Spanish scientists identify changes in dendritic cells during the immune response with promising implications for vaccine design

    Scientists at the CNIC and Hospital de la Princesa-UAM have identified profound changes taking place in dendritic cells during antigen presentation to a lymphocyte via intimate contact called an immune synapse
    De izquierda a derecha: Cristina Sanchez-Ramos, Nieves Garcia-Quintans, David Morera, Mariya Lytvyn, Juan A Bernal, Mª Ángeles Sanguino, Daniel Martín Perez, Fernando de Benito, David Sanz y Emilio Camafeita
    Research
    23 Oct 2023
    Nature Communications: Spanish scientists discover a possible treatment for a heart condition that causes an estimated 20% of sudden deaths among athletes

    This disease, which can trigger sudden death in elite athletes, is caused by genetic mutations that affect proteins responsible for connecting and coordinating the muscle cells (myocytes) in the myocardium the heart’s muscular wall
    la Dra. Mercedes Ricote y la Dra. Ana Paredes
    About the CNIC
    29 Sep 2023
    Researcher Ana Paredes wins the International Birnstiel Award 2023

    The Spanish National Centre for Cardiovascular Research (CNIC) researcher Dr Ana Paredes has won the International Birnstiel Award 2023
    About the CNIC
    24 Sep 2023
    CURE HEART & BRAIN (COFUND): Postdoctoral positions for excellent researchers
    The image represent glucose uptake in the brain measured by positron emission tomography in middle-aged individuals with low (top) or high (bottom) sustained cardiovascular risk over 5 years. The colors represent cerebral glucose consumption, with red indicating higher consumption and blue lower consumption
    Research
    31 Aug 2023
    The Lancet Healthy Longevity: Early action to control cardiovascular risk factors preserves brain metabolism

    A study published in The Lancet Healthy Longevity shows that brain metabolism, detected with advanced imaging techniques, declines more sharply in middle-aged people with a sustained high cardiovascular risk over 5 years